Study identifies new approach to improving treatment for MS and other conditions
(Medical Xpress)—Working with lab mice models of multiple sclerosis (MS), UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved ...
Alzheimer's disease & dementia
May 17, 2013 |
5 / 5 (2) |
0
|
Nonmelanoma skin cancer tied to lower Alzheimer's risk
(HealthDay)—Older individuals with nonmelanoma skin cancer (NMSC) seem to have a significantly reduced risk of developing Alzheimer's disease (AD), according to a study published online May 15 in Neurology.
Alzheimer's disease & dementia
May 16, 2013 |
5 / 5 (1) |
0
Skin cancer may be linked to lower risk of Alzheimer's disease
People who have skin cancer may be less likely to develop Alzheimer's disease, according to new research published in the May 15, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. The li ...
Alzheimer's disease & dementia
May 15, 2013 |
5 / 5 (1) |
0
|
Alzheimer's markers predict start of mental decline
(Medical Xpress)—Scientists at Washington University School of Medicine in St. Louis have helped identify many of the biomarkers for Alzheimer's disease that could potentially predict which patients will develop the disorder ...
Alzheimer's disease & dementia
May 14, 2013 |
3 / 5 (1) |
0
|
Scientists develop drug that slows Alzheimer's in mice
A drug developed by scientists at the Salk Institute for Biological Studies, known as J147, reverses memory deficits and slows Alzheimer's disease in aged mice following short-term treatment. The findings, ...
Alzheimer's disease & dementia
May 13, 2013 |
4.2 / 5 (5) |
0
|
Many seniors suffer mental decline in silence, CDC reports
(HealthDay)—About 13 percent of Americans 60 and older say they have increasing problems with thinking and memory and that they suffer growing confusion, a new report released Thursday shows.
Alzheimer's disease & dementia
May 09, 2013 |
5 / 5 (1) |
0
Alzheimer's disease is associated with removal of the synaptic protein ADAM10
Alzheimer's disease is characterized by the accumulation of neurotoxic β-amyloid peptide (A-beta). ADAM10, a protein that resides in the neural synapses, has previously been shown to prevent the formation of A-beta.
Alzheimer's disease & dementia
May 08, 2013 |
not rated yet |
0
Using anticholinergics for as few as 60 days causes memory problems in older adults
Research from the Regenstrief Institute, the Indiana University Center for Aging Research and Wishard-Eskenazi Health on medications commonly taken by older adults has found that drugs with strong anticholinergic effects ...
Alzheimer's disease & dementia
May 07, 2013 |
5 / 5 (1) |
0
|
Baxter drug fails to slow Alzheimer's in big study (Update)
Baxter International Inc. says that a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of 390 patients with mild to moderate Alzheimer's disease.
Alzheimer's disease & dementia
May 07, 2013 |
not rated yet |
0
Research suggests link between elevated blood sugar, Alzheimer's risk
(Medical Xpress)—A new University of Arizona study, published in the journal Neurology, suggests a possible link between elevated blood sugar levels and risk for developing Alzheimer's disease.
Alzheimer's disease & dementia
May 06, 2013 |
not rated yet |
0
|
Scientists much closer to developing screening test for early detection of Alzheimer's disease
They identified blood-based biological markers that are associated with the build up of a toxic protein in the brain which occurs years before symptoms appear and irreversible brain damage has occurred.
Alzheimer's disease & dementia
May 01, 2013 |
not rated yet |
0
No link between anesthesia, dementia in elderly
Elderly patients who receive anesthesia are no more likely to develop long-term dementia or Alzheimer's disease than other seniors, according to new Mayo Clinic research. The study analyzed thousands of patients using the ...
Alzheimer's disease & dementia
May 01, 2013 |
not rated yet |
1
|
Research spinoff ReXceptor gets license for Alzheimer's treatment
Case Western Reserve's Technology Transfer Office has granted an exclusive license of a novel Alzheimer's Disease (AD) treatment strategy to spinoff company ReXceptor Inc., which plans to initiate early-stage human clinical ...
Alzheimer's disease & dementia
Apr 25, 2013 |
4 / 5 (1) |
0
Suppressing protein may stem Alzheimer's disease process
Scientists funded by the National Institutes of Health have discovered a potential strategy for developing treatments to stem the disease process in Alzheimer's disease. It's based on unclogging removal of ...
Alzheimer's disease & dementia
Apr 25, 2013 |
4.7 / 5 (3) |
0
|
Key mechanism for a common form of Alzheimer's disease discovered
Scientists from the Icahn School of Medicine at Mount Sinai, in collaboration with researchers from Icelandic Heart Association, Sage Bionetworks, and other institutions, have discovered that a network of genes involved in ...
Alzheimer's disease & dementia
Apr 25, 2013 |
4.6 / 5 (5) |
0
|
